Home › Post-COVID Conditions (Long COVID) › NCT07140094
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Long-Covid-19 Alleviation Through Learning Mindfulness Study (LONG-CALM)
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Age \> or = 18 * Willing and able to provide informed consent * Access to the internet * Self-reported history of SARS-CoV-2 infection * Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness Exclusion Criteria: * Participating in another clinical trial of an intervention for PASC symptoms * Engaged in a structured MBI
About the study
This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.
What is being tested
- Structured mindfulness intervention (behavioral)
Sponsor: Columbia University · Participants: 400 · Started: May 21, 2024
Contact the study team
- Deborah Theodore, MD · Phone: 2123058739
Official record on ClinicalTrials.gov — NCT07140094
Locations in the U.S.
| New York | Columbia University, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.